Teleflex Incorporated Highlights Article on ARROW® VPS® Vascular Positioning System, Showing Significant Reduction in Cathe...
January 13 2015 - 8:00AM
Business Wire
Article Shows Advantages of Using System that
Replaces Chest X-Ray to Check Central IV Line Placement
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care and surgery, announced that a
recent peer-reviewed article about the ARROW VPS® Vascular
Positioning System showed the technology can reduce improper
positioning of central IV catheters. The article was published in
the Fall 2014 issue of the Journal of the Association for Vascular
Access (JAVA).
The catheter tip positioning project took place at James A.
Haley Veterans’ Hospital, in Tampa, Fla., and involved use of the
VPS® Technology to place peripherally inserted central catheters
(PICCs). The article in JAVA presents the largest cohort at one
site of patient results in studies using the VPS® System.
The hospital’s PICC team primarily examined whether the system
could reduce the incidence of malpositioned PICCs. Improper PICC
positioning can result in serious complications and delay
potentially lifesaving IV therapy. The article data showed a 51%
reduction of malpositioned catheters when using the VPS System.1
The hospital also wanted to determine whether use of the system
could minimize the use of chest X-rays to confirm accurate PICC
placement, which they were able to achieve.
“It was gratifying for our PICC team’s product trial to
establish a new protocol that benefits patients and the hospital
alike,” said lead author Linda Smith, MSN, RN, CRRN, VA-BC™, CRNI®,
a Vascular Access Nurse and PICC team member at James A. Haley.
“Many of our patients have significant health complications and
PICC placements can be challenging. We identified the positioning
system as a possible improvement to our PICC placement procedures.
Then we evaluated it to make sure it performed as promised, and our
results led to a policy change that has improved the quality and
efficiency of care at our hospital and allowed us to eliminate
confirmatory chest X-ray for most PICC placements.”
Smith is the lead author of the study. The co-authors are
Catherine M. Brown, MSN, RN-BC, RVT and Julie Mendoza, BSN, RN,
VA-BC™.
The ARROW® VPS® Vascular Positioning System combines
intravascular electrocardiogram (ECG), intravascular Doppler
ultrasound and a software algorithm, to accurately place catheter
tips in the lower one-third of the Superior Vena Cava-Cavo Atrial
Junction (SVC-CAJ). The system displays a Blue Bullseye on the
screen when an accurate placement has been made at the SVC-CAJ. The
VPS® Device is FDA-cleared to eliminate chest X-ray in adult
patients, when a steady Blue Bullseye is achieved.
The PICC team at James A. Haley Veterans’ Hospital evaluated the
positioning system to assess effectiveness and potential advantages
in the following areas:
- Real-time guidance. The
positioning system helps prevent malposition by guiding central
venous catheter placements in real time. A confirmatory chest X-ray
is a retrospective image that can only reveal a malposition, not
prevent it.
- Reduced X-ray exposure. Many
patients are exposed to radiation from a variety of screenings and
eliminating a confirmatory chest X-ray helps reduce that
exposure.
- Fewer treatment delays. The
X-ray process can delay treatment by up to several hours, depending
on the hospital. If the X-ray shows that a malpositioned catheter
needs to be adjusted, the delay is even greater.
- Reduced procedure time.
Eliminating confirmatory chest X-rays makes more efficient use of
radiologists’ and nurses’ time.
"It's always heartening to see nurses contribute to the medical
literature, and this is an important article for several reasons,”
said Jay White, President, Vascular Division of Teleflex. “It
documents one key way in which vascular access nurses can use
advanced technology to provide services that may save hospitals
both staff time and money. This paper also supports the goal many
hospitals have to protect patients from unnecessary exposure to
radiation, and Teleflex Incorporated is pleased that our VPS®
Technology is part of that effort."
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care and surgery. Our
mission is to provide solutions that enable healthcare providers to
improve outcomes and enhance patient and provider safety.
Headquartered in Wayne, PA, Teleflex employs approximately 11,500
people worldwide and serves healthcare providers in more than 150
countries. Additional information about Teleflex can be obtained
from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
VA-BC is a trademark or registered trademark of The Vascular
Access Certification Corporation.
CRNI is a trademark or registered trademark of The Infusion
Nurses Certification Corporation.
Teleflex, Arrow and VPS are trademarks or registered trademarks
of Teleflex Incorporated or its affiliates.© 2014 Teleflex
Incorporated. All rights reserved. MC-000311
References:
1. Smith L, Brown CM, Mendoza J. Novel catheter positioning
system for intravenous central lines: a report of 1 hospital's
experience. J Vasc Access. 2014;19(3):167-171.
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor
Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024